new glp 1 gip drug Retatrutide for weight loss: Study shows 30% body weight loss GLP-1 use tripled among non-diabetics,

Exercise boosts energy, supports muscle tone, and helps maintain weight loss once the medicine starts working

Forecasting Methods Time-series modelling S-curve and diffusion models (for emerging technologies) Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes) Price elasticity models Market maturity and lifecycle-based projections Scenario Analysis Given inherent uncertainties, three scenarios were constructed: Base-Case Scenario: Expected trajectory under current conditions Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds Conservative Scenario: Slow adoption, regulatory delays, economic constraints Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption

29 In fact, less frequent dosing has been recommended as a strategy to maintain weight loss, 16 and some patients maintain weight loss with only one dose per month

The results were shown that the serum TC and TG contents of mice in the model group and the Lira group were significantly increased compared with the control group

Ozempic EPAR - Public Assessment Report

Tirzepatide (Mounjaro) has also been shown to significantly reduce the severity of sleep apnoea, mostly because weight loss puts less pressure on the airways